Questcor Pharmaceuticals, Inc. is a specialty biopharmaceutical company which provides products for patients with serious, difficult-to-treat autoimmune and inflammatory disorders. We support research in a number of rare conditions, including in treatment-resistant patient populations, in which there is significant need for improved therapeutic options. Questcor was awarded Forbes’ Magazine’s #1 Best Small Company award in 2011, #7 in 2012, and Orange County Register’s #1 Best Large Company of 2012.
The Company booked $548 million in net sales during the 12 months ended March 31, 2013, which represents a 500% increase from the equivalent period ended three years ago. The Company has solid margins, positive cash flow, a strong product base and a dedicated US sales force. Excellent top line growth momentum continues as Questcor continues to pursue its growth strategy. Market capitalization is approximately $3.8 Billion.
We are currently seeking an Acthar Specialist, Nephrology.
Responsibilities:
The successful candidate will be able to show documented success as a top producer. They will effectively manage their territory as a results-oriented sales person, business partner and consultant. They will develop strategically targeted, accounts and specific business plans that reflect an in-depth understanding of local, regional and national market forces impacting product sales. The incumbent will skillfully deal with the concepts and complexities associated with the products and adjunctive therapies and must demonstrate an in-depth understanding of the clinical data.
Qualifications:
- Bachelor degree
- 3-5 years pharmaceutical sales experience
- At least one year of Nephrology experience is required
- Local travel; some overnight required (10-20%)
Questcor provides competitive salary, bonus and a full range of benefits (100% paid for employee & 90% paid for dependents), 401(k), ESPP and stock options.
For more information, you may view our website at http://www.questcor.com/careers/company-benefits .
Questcor is an Equal Opportunity Employer.
News Source
0 comments:
Post a Comment